Invest in generics as a lesson from the shortages of chemotherapy.

Published Date: 05 Jan 2024

More long-term fixes are required to guarantee treatment access.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

2.

Adult overdose deaths on the rise

3.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

4.

A promising medication could slow brain tumors in children.

5.

US Counties Suffered Significantly from a Lack of Psychiatric Care.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot